U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07751029) titled 'Haelan 951 for Menopause Symptoms in Peri- and Postmenopausal Women' on July 28.
Brief Summary: This proof-of-concept, open-label, single-arm study is designed to evaluate the effects of daily consumption of Haelan 951, a fermented soy conventional food product, on self-reported menopausal vasomotor symptoms, sleep quality, and health-related quality of life in peri- and postmenopausal women. The study will collect descriptive data on participant-reported outcomes over the study period to assess the feasibility and potential effects of Haelan 951 in supporting menopausal wellness. The study is not intended to evaluate the treatment, ...